nipradilol has been researched along with Hypertension, Portal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akita, H; Kawafune, T; Kubota, M; Okajima, T; Sugano, S; Sumino, Y; Suzuki, T | 1 |
Cailmail, S; Lebrec, D; Ohsuga, M | 1 |
Imai, F | 1 |
Aramaki, T; Katsuta, Y; Komeichi, H; Kurokawa, H; Ohsuga, M; Okumura, H; Satomura, K; Sekiyama, T; Terada, H; Tsutsui, H | 1 |
1 review(s) available for nipradilol and Hypertension, Portal
Article | Year |
---|---|
[Drug therapy for the treatment of portal hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Combined Modality Therapy; Diuretics; Female; Humans; Hypertension, Portal; Male; Middle Aged; Nitroglycerin; Portal Pressure; Propanolamines; Sclerotherapy; Somatostatin; Spironolactone; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1996 |
1 trial(s) available for nipradilol and Hypertension, Portal
Article | Year |
---|---|
Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Blood Flow Velocity; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Propanolamines; Vascular Resistance; Vasodilator Agents; Venous Pressure | 1995 |
2 other study(ies) available for nipradilol and Hypertension, Portal
Article | Year |
---|---|
Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Blood Circulation; Hemodynamics; Hypertension, Portal; Male; Pharmaceutical Vehicles; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Splanchnic Circulation | 1993 |
Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Hemodynamics; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Middle Aged; Propanolamines; Propranolol; Time Factors; Vasodilation; Vasodilator Agents | 1992 |